Equation chapter 1 section 1A new method for predicting human hepatic clearance from in vitro experimental data using molecular descriptors

Archives of Pharmacal Research

Volumn 30, Issue 2, 2007, Pages 182-190

  Lee, Soyoung ^a   Kim, Dongsup ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Hepatic clearance; In vitro data; Molecular descriptors; Multiple linear regression; Prediction

Indexed keywords

EID: 33947125972     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02977693     Document Type: Article

References (27)

1. Boxenbaum, H., Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J. Pharmacokinet. Biopharm., 10, 201-227 (1982).
2. Clark, D. E., In silico prediction of blood-brain barrier permeation. Drug Discov. Today, 8, 927-933 (2003).
3. Didziapetris, R., Japertas, P., Avdeef, A., and Petrauskas, A., Classification analysis of P-glycoprotein substrate specificity. J. Drug Target., 11, 391-406 (2003).
4. Doniger, S., Hofmann, T., and Yeh, J., Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms. J. Comput. Biol., 9, 849-864 (2002).
5. Ertl, P., Rohde, B., and Selzer, P., Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem., 43, 3714-3717 (2000).
6. Hayter, A. J., Probability and Statistics for Engineers and Scientists, Duxbury (2002).
7. Hou, T. J. and Xu, X. J., ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors. J. Chem. Inf. Comput. Sci., 43, 2137-2152 (2003).
8. Houston, J. B., Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol., 47, 1469-1479 (1994).
9. Ito, K. and Houston, J. B., Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharm. Res., 21, 785-792 (2004).
10. Ito, K. and Houston, J. B., Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches. Pharm. Res., 22, 103-112 (2005).
11. Jolivette, L. J. and Ward, K. W., Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. J. Pharm. Sci., 94, 1467-1483 (2005).
12. Kola, I. and Landis, J., Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov., 3, 711-715 (2004).
13. Langowski, J. and Long, A., Computer systems for the prediction of xenobiotic metabolism. Adv. Drug Deliv. Rev., 54, 407-415 (2002).
14. Lave, T., Dupin, S., Schmitt, C., Chou, R. C., Jaeck, D., and Coassolo, P., Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. J. Pharm. Sci., 86, 584-590 (1997).
15. Leach, A. and Gillet, V., An Introducton to Chemoinformatics, Kluwer Academic Publishers (2003).
16. Lewis, D. F. and Dickins, M., Substrate SARs in human P450s. Drug Discov. Today, 7, 918-925 (2002).
17. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 46, 3-26 (2001).
18. Nagilla, R. and Ward, K. W., A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans. J. Pharm. Sci., 93, 2522-2534 (2004).
19. Naritomi, Y., Terashita, S., Kimura, S., Suzuki, A., Kagayama, A., and Sugiyama, Y., Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Drug Metab. Dispos., 29, 1316-1324 (2001).
20. Norinder, U. and Haeberlein, M., Computational approaches to the prediction of the blood-brain distribution. Adv. Drug Deliv. Rev., 54, 291-313 (2002).
21. PreADME, http://preadmet.bmdrc.org/preadmet/index.php
22. Schneider, G., Coassolo, P., and Lave, T., Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques. J. Med. Chem., 42, 5072-5076 (1999).
23. Shargel, S. andYu, A., Applied Biopharmaceutics and Pharmacokinetics, Prentice-Hall International, Inc (1993).
24. Shim, C., Pharmacokinetics, Seoul National University Publishers (1994).
25. Sugawara, M., Takekuma, Y., Yamada, H., Kobayashi, M., Iseki, K., and Miyazaki, K., A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction. J. Pharm. Sci., 87, 960-966 (1998).
26. van de Waterbeemd, H. and Gifford, E., ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov., 2, 192-204 (2003).
27. Wajima, T., Fukumura, K., Yano, Y., and Oguma, T., Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis. J. Pharm. Sci., 91, 2489-2499 (2002).